IceCure Medical Ltd.

Biotech Caesarea, L3

About

Issuer

Entity type
Corporation
Jurisdiction
Israel
Sector
Biotech
Headquarters
Caesarea, L3
Street
7 Ha'eshel St
Zip
3079504

Offering

Total offering
$4M
Amount sold
$4M
First sale
Mar 26, 2026
Min investment
$0
Securities
—
Federal exemption
Rule 506(b)
Investors so far
5

How this filing compares

Ranked #13 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.7× the median.

Other L3 filings this week: Eshbal Functional Food Inc., ION Private Equity Fund US L.P.

Leadership

Eyal Shamir — Executive Officer (also: Director)

Ronen Tsimerman — Executive Officer

Ron Mayron — Director

Shay Levav — Executive Officer

Naum Muchnik — Executive Officer

Tlalit Bussi Tel-Tzure — Executive Officer

Merav Nir Dotan — Executive Officer

Shad Good — Executive Officer

Vincent Chun Hung Chan — Director

Yang Huang — Director

Sharon Levita — Director

Yonatan Malca — Director

Filing details

IceCure Medical Ltd. filed a Form D with the SEC on March 31, 2026.

Other newest Biotech companies

Other newest companies in L3